← Back to Patent Explorer
US4440759A Expired / Lapsed US ⏱️ 0.0 years remaining

20-Amino tylosin derivatives and pharmaceutical compositions containing same

Assignee: Individual
•
Filing: 1983-02-24
•
Granted: 1984-04-03
•
Expires: 2003-02-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 20-Amino derivatives of tylosin and desmycosin are active against bacteria and Mycoplasma.

Inventors

  • 👤 Satoshi Omura
  • 👤 Akira Nakagawa

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 18:08
CPC Classifications
C; C07; C07H; C07H17/00; C07H17/04; C07H17/08; A; A61; A61P; A61P31/00; A61P31/04

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 145 words
A macrolide of formula (I): ##STR9## where R is mycinosyloxy, where Q is hydrogen or mycarosyl, where X is a group of formula: ##STR10## where: (i) R 10 and R 11 independently represent C 1-4 alkyl, C 3-10 cycloalkyl; or a group of formula: --(CH.sub.2).sub.n --Ph where n is 0, 1 or 2, and Ph is phenyl or phenyl substituted by a C 1-4 alkoxycarbonyl, amino, halogen, C 1-4 alkyl or C 1-4 alkoxy group; (ii) one only of R 10 and R 11 represents hydrogen or a group of formula: ##STR11## where R 12 is hydrogen or C 1-4 alkyl, or (iii) R 10 and R 11 taken together with the adjacent nitrogen atom form a heterocyclic ring selected from piperazino and morpholino; or a pharmaceutically-acceptable salt, or an acyl ester derived from a monocarboxylic acid having from 2 to 7 carbon atoms, thereof.
Claim 2
Dependent Claim 145 words
A macrolide of formula (I): ##STR9## where R is mycinosyloxy, where Q is hydrogen or mycarosyl, where X is a group of formula: ##STR10## where: (i) R 10 and R 11 independently represent C 1-4 alkyl, C 3-10 cycloalkyl; or a group of formula: --(CH.sub.2).sub.n --Ph where n is 0, 1 or 2, and Ph is phenyl or phenyl substituted by a C 1-4 alkoxycarbonyl, amino, halogen, C 1-4 alkyl or C 1-4 alkoxy group; (ii) one only of R 10 and R 11 represents hydrogen or a group of formula: ##STR11## where R 12 is hydrogen or C 1-4 alkyl, or (iii) R 10 and R 11 taken together with the adjacent nitrogen atom form a heterocyclic ring selected from piperazino and morpholino; or a pharmaceutically-acceptable salt, or an acyl ester derived from a monocarboxylic acid having from 2 to 7 carbon atoms, thereof.
Claim 3
Dependent Claim 10 words
A compound of claim 1 in which Q is hydrogen.
Claim 4
Dependent Claim 23 words
A compound of claim 1 in which X represents a group selected from dimethylamino, anilino, N-methylanilino, o-ethoxycarbonylanilino, benzylamino, aminobenzylamino, halobenzylamino, cyclohexylamino and morpholino.
Claim 5
Dependent Claim 8 words
The compound of claim 3 which is 20-deoxo-20-(N-methylanilino)tylosin.
Claim 6
Dependent Claim 8 words
The compound of claim 3 which is 20-deoxo-20-(N-benzylamino)demycarosyltylosin.
Claim 7
Dependent Claim 8 words
The compound of claim 3 which is 20-deoxo-20-(N-morpholino)demycarosyltylosin.
Claim 8
Dependent Claim 34 words
A method of suppressing or treating microbial infections caused by gram-positive bacteria or Mycoplasma in a warm-blooded animal which comprises administering to said warm-blooded animal a chemotherapeutically-effective amount of a compound of claim 1.
Claim 9
Dependent Claim 31 words
A method of suppressing or treating microbial infections caused by Pasteurella in a warm-blooded animal which comprises administering to said warm-blooded animal a chemotherapeutically-effective amount of a compound of claim 2.
Claim 10
Dependent Claim 32 words
A feed premix comprising as an active ingredient an amount of a compound of claim 1 which is effective to suppress or treat microbial infections caused by gram-positive bacteria, Mycoplasma or Pasteurella.
Claim 11
Dependent Claim 43 words
A veterinary formulation which comprises as an active ingredient an amount of a compound of claim 1 which is effective to suppress or treat microbial infections caused by gram-positive bacteria, Mycoplasma or Pasteurella associated with one or more physiologically-acceptable carriers or vehicles therefor.

References Cited (Backward Citations)

US3178341A Cited
US4196280A Cited
US4345069A Cited
US4279896A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-04-03 1987-10-03 1988-04-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-04-03 1991-10-03 1992-04-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-04-03 1995-10-03 1996-04-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag